CURRICULUM VITAE

JAMES H. MUCHMORE, M.D.

PERSONAL DATA

Date of Birth: October 4, 1943

Place of Birth: Memphis, Tennessee

Office Address: PO Box 60

New Vernon, New Jersey 07976

Office Telephone: 201-***-****

Home Address: 57 Gaston Road

Morristown, NJ 07960

Home Telephone: 973-***-****

Cell Telephone: 201-***-****

E-mail: ac2qub@r.postjobfree.com

Social Security Number: per request

EDUCATION

Medical Degree: University of Bologna

School of Medicine

Bologna, Italy 1975

Bachelor of Arts Degree: University of North Carolina

Chapel Hill, North Carolina 1966

Languages: Fluent English and Italian,

Reading knowledge French, Spanish, and German

ACADEMIC EXPERIENCE

Clinical Associate Professor - Gratis

Department of Surgery

Louisiana State University – Shreveport

Shreveport, Louisiana 2005-2014

Clinical Associate Professor

Department of Surgery

Tulane University School of Medicine

New Orleans, Louisiana 2003-

Associate Professor

Department of Surgery

Surgical Oncology Section

Tulane University School of Medicine

New Orleans, Louisiana 1989-2002

Assistant Professor

Department of Surgery

Surgical Oncology Section

Tulane University School of Medicine

New Orleans, Louisiana 1983-1989

Instructor

Department of Surgery

Surgical Oncology Section

Tulane University School of Medicine

New Orleans, Louisiana 1982-1983

PROFESSIONAL EXPERIENCE

Fellow

Department of Surgery

Surgical Oncology Section

Tulane University School of Medicine

New Orleans, Louisiana 1981-1982

Chief Surgical Resident

Bridgeport Hospital

Bridgeport, Connecticut 1980-1981

Surgical Oncology Resident

Memorial Sloan-Kettering Cancer Center

New York, New York 1980

General Surgery Resident

Bridgeport Hospital

PGY-3 and PGY-4

Bridgeport, Connecticut 1979-1980

Surgical Oncology Resident

Memorial Sloan-Kettering Cancer Center

New York, New York 1979

General Surgery Resident

Bridgeport Hospital

PGY-3

Bridgeport, Connecticut 1978-1979

General Surgery Resident

Morristown Memorial Hospital

PGY-1 and PGY-2

Morristown, New Jersey 1976-1978

General Internship

Fifth Channel Program

Rutgers Medical School

Piscataway, New Jersey 1975-1976

RESEARCH AND TEACHING EXPERIENCE

Fellow

American College of Surgeons

Department of Surgery

Tulane University School of Medicine

New Orleans, Louisiana 1989-

Instructor

American College of Surgeons

Advanced Trauma Life Support Course

Department of Surgery

Tulane University School of Medicine

New Orleans, Louisiana 1987-1989

Instructor

American College of Surgeons

Cancer Management Course

New Orleans, Louisiana 1986

Instructor of Medical Students

Presenter of Junior Core Lectures

Tulane University School of Medicine

Department of Surgery

New Orleans, Louisiana 1981-1994

HOSPITAL APPOINTMENTS

Associate (Provisional) Staff

Department of Surgery

St. Clare’s Hospital

Denville, New Jersey 2003-2006

Associate (Provisional) Staff

Department of Surgery

Morristown Memorial Hospital

Morristown, New Jersey 2002-2005

Attending Surgeon

Huey P. Long Medical Center

Pineville, Louisiana 1983-2014

Chief of Surgery

Huey P. Long Medical Center

Pineville, Louisiana 1997-2002

Medical Director

Clinical Cancer Research Unit

Charity Hospital of Louisiana at New Orleans

New Orleans, Louisiana 1985-1994

Attending Surgeon

Pendleton Memorial Methodist Hospital

New Orleans, Louisiana 1985-1994

Attending Surgeon

Touro Infirmary

New Orleans, Louisiana 1983-1994

Attending Surgeon

Veterans Administration Medical Center

Alexandria, Louisiana 1983-1991

Attending Surgeon

Tulane University Hospital and Clinic

New Orleans, Louisiana 1982-2000

Attending Surgeon

Charity Hospital of Louisiana at New Orleans

New Orleans, Louisiana 1981-1994

LOCUM TENENTS WORK

Emergency Staffing Solutions (ESS) 2014-

Correct Care, INC 2014-

AWARDS AND HONORS

American Cancer Society, Inc. Clinical

Oncology Fellowship, Tulane University School

of Medicine, Department of Surgery, New

Orleans, Louisiana 1981

Second Prize for Paper Presented on Trauma,

Annual Meeting, The Connecticut Society of the

American Board of Surgeons and the American

College of Surgeons, Farmington, Connecticut 1980

Honorable Mention for paper presented on Trauma,

Annual Meeting, The Connecticut Society of the

American Board of Surgeons and the American

college of Surgeons, Meriden, Connecticut 1979

Graduation cum laude, University of Bologna

School of Medicine, Bologna, Italy 1975

CERTIFICATION

American Board of Surgery 1983

RECERTIFICATION

American Board of Surgery 1994, 2002

CURRENT LICENSURES

Louisiana 1981-

New Jersey 2002-2008

New Hampshire 1994

EDITORIAL BOARD

Regional Cancer Treatment Journal 1988-1998

European Journal of Surgical Oncology 2013 -

SPECIAL AREAS OF INTEREST

Surgical Oncology

Advanced Colon Cancer and Liver Metastases

Melanoma and Sentinel Lymph Node Biopsy

Soft Tissue Sarcoma

Benign and Malignant Breast Diseases

Laparoscopic Surgery

CLINICAL RESEARCH INTEREST

Breast Cancer Clinical Trials

Regional Chemotherapy

Regional Drug Delivery

Tumor Cell Microenvironment

CURRENT SOCIETY MEMBERSHIPS

Cancer Institute of New Jersey 2003-2005

Eastern Cooperative Oncology Group 2003-2005

Society of Surgical Oncology 1992-

Tulane Surgical Society, Founding Member 1990-

Southeastern Surgical Congress 1990-1998

American College of Surgeons, Fellow 1988-

Surgical Association of Louisiana 1987-1994

New Orleans Surgical Society 1987-1994

American Society for Parenteral and Enteral Nutrition 1987-1994

American Association for Cancer Education 1986-1994

North American Perfusion Group 1985-1998

Orleans Parish Medical Society 1985-1994

Louisiana State Medical Society 1985-1994

World Health Organization Melanoma Programme 1984-2008

Southwest Oncology Group 1984-1994

National Surgical Adjuvant Project for Breast 1984-1994

and Bowel Cancers

Association for Academic Surgery 1984-2003

American Medical Association 1978-1994

COMMITTEES

Cancer Committee

Founder & Chairman

Huey p. Long Medical Center

Pineville, Louisiana 1995-2002

Tumor Registry Subcommittee

Tulane Medical Center Hospital and Clinic

New Orleans, Louisiana 1988-1994

Pharmacy and Therapeutics Committee

Tulane Medical Center Hospital and Clinic

New Orleans, Louisiana 1988-1994

Cancer Committee

Charity Hospital of Louisiana at New Orleans

New Orleans, Louisiana 1985-1994

Ad Hoc Committee of Long-Term Vascular Access

Chairman

Charity Hospital of Louisiana at New Orleans

New Orleans, Louisiana 1985-1994

Nutrition Care Committee

Charity Hospital of Louisiana at New Orleans

New Orleans, Louisiana 1984-1994

Nutrition Care Subcommittee

Chairman

Tulane Medical Center Hospital and Clinic

New Orleans, Louisiana 1983-1993

ADVANCED COURSES

American Heart Association

Advanced Cardiac Life Support 2016

American Heart Association

Pediatric Advanced Life Support (PALS) 2016

American College of Surgeons

Advanced Trauma Life Support 2014

American Heart Association

Pediatric Advanced Life Support (PALS) 2014

American Heart Association

Advanced Cardiac Life Support Course 2014

Laparoscopic Colon Surgery 2005

American Heart Association

Advanced Cardiac Life Support Course 2005

American Heart Association

Advanced Cardiac Life Support Course 2003

Critical Care & Emergency Medicine

Univ of Florida, Depart Anesthesiology 2001

American College of Surgeons

Advanced Life Support Course 1987

American Heart Association

Advanced Cardiac Life Support Course 1988

RESEARCH FUNDING

Biomedical Research Support Grant Funds:

"Analysis of Surface Antigen HLA-DR Expression in Malignant Melanoma"

Principal Investigator

Period of 10/01/84-09/30/85; Direct Cost: $5,000; Percent Time: 5%

Biomedical Research Support Grant Funds:

"Analysis of Surface Antigen HLA-DR Expression in Malignant Melanoma"

Principal Investigator

Period of 09/01/85-02/28/87; Direct Cost: $4,000; Percent Time: 5%

Adria Laboratories:

"Comparative Efficacy and Safety of a Combination of Epirubicin Plus 5-Fluorouracil vs. 5-Fluorouracil Alone and Epirubicin Alone in the Treatment of Locally Advanced or Disseminated Gastric Cancer"

Principal Investigator

Period of 03/13/85-06/18/87; Direct Cost: $2,500; Percent Time: 5%

National Institutes of Health:

"Southwest Oncology Group"

Principal Investigator: Walter J. Stuckey, M.D.

Period of 01/01/86-12/31/86; Direct Cost: $113,210; Percent Time: 5%

Caremark, Inc./Clintec International Inc.:

"Nutritional Support Research"

Principal Investigator

Period of 10/01/89-09/30/90; Direct Cost: $40,000; Percent Time: 10%

Plastik Fur Die Medizin GmhB.:

"Drug filtration in high-dose regional chemotherapy for regionally confined melanoma, and cancers of the stomach, colon, breast and pancreas"

Principal Investigator

Period of 08/01/90-07/3191; Direct Cost: $20,000;

Percent Time: 6%

Plastik Fur Die Medizin Gmhb.:

"Drug filtration in high-dose regional chemotherapy"

Principal Investigator

Period of 05/01/94 through 04/30/97; Requested Direct Cost:

$351,361; Percent Time: 5%

Funded at $100,000; over 3 years.

Delcath Systems Inc.:

“Data Summary Report for the FDA on the use of Adriamycin both systemic and regional for the treatment of hepatic malignancies”

Principal Investigator

Period of 02/01/97 through 06/01/97

Funded at $11,000

PUBLICATIONS

BOOKS

Muchmore JH: Adult Parenteral Nutrition: A Clinical Manual of Principles and Techniques. Tulane Medical Center Hospital, New Orleans, Louisiana, 1987

BOOK CHAPTERS

1. Krementz, ET, Muchmore JH: Soft tissue sarcomas behavior and management. In MacLean LD (ed), Advances in Surgery, Volume 16, Yearbook Medical Publishers, Inc., Chicago-London, 1983; pp 147-196

2. Krementz ET, Sutherland CM, Carter RD, Muchmore JH: Limb perfusion in malignant melanoma. In Mackie R (ed), Clinics in Oncology, Volume 3, Number 3, WB Saunders Co., Ltd, London, 1984; pp 531-554

3. Krementz ET, Ryan, Muchmore JH et al. Hyperthermic regional perfusion for melanoma of the limbs. In Cutaneous Melanoma: Clinical Management and Treatment Results Worldwide. J. B. Lippincott Co.' Philadelphia, PA, 1985; pp 171-195

4. Krementz ET, Muchmore JH, Carter RD, Sutherland CM: Regional intra-arterial chemotherapy of cancer by perfusion and infusion. In McKenna Rd, Murphy GP (eds), Fundamentals of Surgical Oncology, MacMillan Publishing Co., Inc., New York, 1986; pp 894-906

5. Krementz ET, Muchmore JH, Carter RD, Sutherland CM: Regional chemotherapy for melanoma of the limbs. In Aigner KR, Patt YZ, Link KH, Kreidler J (eds), Regional Cancer Treatment, Karger Basel Munchen, New York, 1988; pp 247-260

6. Sutherland CM, Krementz ET, Carter RD, Muchmore JH: Randomized trials of heated perfusion of extremity melanoma. In Malignant Melanoma: Biology, Diagnosis, and Therapy, Kluwer Academic Publishers, Boston, Dordrecht, London, 1988; pp 173-176

7. Wanebo HJ, Little VR, Muchmore JH: Regional perfusion for extremity lesions. IN Lokich JJ (ed), Cancer Chemotherapy by Infusion. Precept Press, Inc., 1990; pp 599-618

8. Meyer M, Muchmore JH, Krementz ET: Pre- and perioperative perfusion chemotherapy for soft tissue sarcoma of the limbs.

Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment, 9:105-126, 1991

9. Muchmore JH, Krementz ET, Carter RD et al. Concomitant high-dose intra-arterial chemotherapy and hemofiltration in treating advanced regional abdominal malignancies, Mitomycin C in Cancer Chemotherapy Today, Excepta Medica, Ltd., Tokyo, Japan, 1991; pp 72-82

10. Muchmore JH, Krementz ET, Reed RJ et al. Melanoma of the hand and foot (Volar subungual melanoma). In Cutaneous Melanoma, J.B. Lippincott Co., Philadelphia, PA, 1992; 25:302-311

11. Raff JH, Muchmore JH. Sarcomas of the upper extremity; lymphangiosarcoma. In Raft JH (ed), Soft Tissue Sarcoma, Diagnosis and Treatment, Mosby, St. Louis, 1993; pp 85-100

12. Muchmore JH. Regional intra-arterial chemotherapy for advanced colorectal cancer, In Wanebo HJ (ed), Colorectal Cancer, Mosby, St. Louis, 1993: pp 464-473.

13.Muchmore JH, Aigner KR, Beg MH. Regional chemotherapy for advanced colorectal cancer. In Cohen AM, Winawer SJ (eds), Cancer of the Colon, Rectum, and Anus, McGraw-Hill, New York 1994, pp 881-889.

14. Krementz ET, Sutherland CM, Muchmore JH. Isolated hyperthermia chemotherapy perfusion for limb melanoma. In Leong SP,(ed), Malignant Melanoma, Surg Clin North Am 1966, pp 1313-1330.

15. Muchmore, JH. Regional Chemotherapy of Cancer of the Pancreas

In: Markman M, (ed), Regional Chemotherapy, 2000, pp 101-125.

16. Muchmore, JH., Wanebo HS. Regional Chemotherapy: An Overview. In Wanebo HS, (ed) Surg Oncol Clin North Am, Elsevier & Saunders, 2008; 17:709-730.

17. Muchmore JH. Drug Removal Systems and Induction Chemotherapy In: Stephens F & Aigner KA (eds), Springer, Berlin Heidelberg, Induction Chemotherapy 2012; pp 31-42.

18. Muchmore JH. Drug Removal Systems and Induction Chemotherapy In: Stephens F & Aigner KA (eds),_Induction Chemotherapy 2012, (German Edition).

19.Muchmore JH. Drug Removal Systems and Induction Chemotherapy In: Stephens F & Aigner KA (eds), Springer, Berlin Heidelberg, Induction Chemotherapy 2016 2nd Edition, pp 31 – 43.

PUBLICATIONS

1. Takai S, Borun TW, Muchmore JH, Leiberman I: Concurrent synthesis of histones and deoxyribonucleic acid in liver after partial hepatectomy. Nature 219: 260-861, 1968

2. Manzoli FA, Muchmore JH, Bonora B, Sabbioni A, Stefoni S: Interazioni dell'acido deossiribonucleico con i lipidi (Interactions of DNA with lipids). Arch It Anat Embriol LXXVI, 1971

3. Manzoli FA, Muchmore JH, Bonora B, Sabioni A, Stefoni S: Interaction between sphingomyelin and DNA. Biochim Biophys Acta 277:251-255, 1972

4. Muchmore J, Bonora B, Sabioni AR, Manzoli-Guidotti L: Interazione degli acidi grassi con il DNA (Interaction of fatty acids with DNA). Arch It Anat Embriol LXXXVII, 1972

5. Muchmore J, Bonora B, Sabioni AR, Manzoli-Guidotti L: Interazione dei lipidi con il DNA in presenza di sali (Interaction of lipids with DNA in the presence of ionic salts). Arch It Anat Embriol LXXXVII, 1972

6. Capitani S, Muchmore J, Bartoli S, Bonora B, Facchini A: Interazione DNA-istoni argininici-sfingomielina (Interaction of DNA-arginine-rich histones-sphingomyelin). Arch It Anat Embriol LXXXVIII, 1973

7. Capitani S, Muchmore J, Bartoli S, Bonora B, Facchini A, Farulla A: Interazione DNA-istoni totali-sfingomielina (Interaction of DNA-total histone proteins-sphingomyelin). Arch It Anat Embriol LXXXVIII, 1973

8. Muchmore J, Bartoli S, Capitani S, Bonora B: Interazione DNA-istoni lisinici-sfingomielina (Interaction of DNA-lysine-rich histones-sphingomyelin). Arch It Anat Embriol LXXXVIII, 1973

9. Capitani S, Muchmore S, Cocco L, Facchini A, Antonucci A: Studio dell'interazione fra nucleoistoni e fosfolipidi. Analisi del complesso DNA-F2b-sfingomielina (Study of interaction of nucleohistone with phospholipids. Analysis of DNA-F2b complex-sphingomyelin). Arch It Anat Embriol LXXXIX, 1974

10. Capitani S, Muchmore J, Geraci E, Casali AM, Manzoli FA: Interazione DNA-istoni-lipidi, analisi del complesso DNA-istoni totali-sfingomielina (Interaction of DNA-histone-lipids, analysis of total histone-DNA-sphingomyelin complex). Boll Soc It Biol Sper 50:1476-1479, 1974

11. Manzoli FA, Capitani S, Muchmore JH: Interazione fra nucleoistoni e fosfolipidi. Analisi del complesso DNA-F1-sfingomielina (Study of the interaction of phospholipids with nucleohistones (Analysis of the DNA-F1 complex with sphingomyelin). Acta Embryol Experim 2:3432-344, 1974

12. Manzoli FA, Muchmore JH, Bonora B, Capitani S, Bartoli S: Lipid-DNA interactions II: Phospholipids, cholesterol, glycerophosphorylcholine, sphingosine and fatty acids. Biochim Biophys Acta 340:1-15, 1974

13. Muchmore JH, Capitani S, Cocco L, Facchini A, Antonucci A: Interazione DNA-fosfolipidi-colesterolo (Interaction of DNA-phospholipids-cholesterol). Arch It Anat Embriol LXXXIX, 1974

14. Muchmore JH, Capitani S, Farulla A, Kovacs S, Manzoli FA: Stabilization by sphingomyelin of calf thymus histone-DNA complexes. IRCS 2:1932, 1974

15. Capitani S, Muchmore JH, Maraldi N, Manzoli FA: Interaction of calf thymus F1 histone-DNA complex with phospholipids. IRCS 3:312, 1975

16. Capitani S, Novello F, Muchmore JH, Manzoli FA: Effect of phospholipids on template activity of calf thymus DNA using DNA polymerase I from E. coli. IRCS 3:264, 1975

17. Manzoli FA, Maraldi NM, Muchmore JH, Capitani S: Analisi dell' interazione nucleoistoni-lipid: DNA-F2b istone-fosfolipidi (Analysis of interaction of nucleohistone with lipids: F2b histone-DNA complex and phospholipids). Acta Embryol Experim 3:285-286, 1975

18. Novello F, Muchmore JH, Bonora B, Capitani S, Manzoli FA: Effect of phospholipids on the activity of DNA polymerase I from E. coli. It J Biochem 24:325-334, 1975

19. Maraldi NM, Capitani S, Muchmore JH, Cocco L, Manzoli FA: Analisi ultrastrutturale di complessi costituiti da istoni purificati ( Ultrastructural analysis of complexes formed by purified histones. Riv Istoch Norm Pat 20:122-123, 1976

20. Capitani S, Muchmore JH, Maraldi N, Palka C, Manzoli FA: Nucleohistone-lipid interaction (DNA-F2b-histone-phospholipids). Riv Istoch Norm Pat 20:124, 1976

21. Manzoli FA, Muchmore JH, Capitani S, Bonora B, Bartoli S: Lipid-F1 nucleohistone interactions. Mol Cell Biochem 10:153-160, 1976

22. Maraldi NM, Capitani S, Muchmore JH, Antonucci A, Manzoli FA: Ultrastructure of self-assembled histones. J Submicr Cytol 8:137-148, 1976

23. Sutherland CM, Muchmore JH: Treatment of metastatic carcinoma of the breast. Female Patient 7:34-39, 1982

24. Sutherland CM, Brown JE, Muchmore JH: Hepatic toxicity from adjuvant chemotherapy after small-bowel bypass. JAMA 248:171, 1982.

25. Sutherland CM, Muchmore JH, Browder IW, Vega PJ: Chronic calcific pancreatitis with pancreatic duct lithiasis secondary to stenosing papillitis. So Med J 76:1318-1319, 1983

26. Sutherland CM, Muchmore JH, Ball JE, Cerise EJ: The effect of impaired renal function on tamoxifen. J Surg Oncol 27:222-223, 1984

27. Muchmore JH, Carter RD, Krementz ET: Regional perfusion for malignant melanoma and soft tissue sarcoma: A review. Cancer Invest 3:129-143, 1985

28. Hornung MO, Krementz ET, Sullivan KA, Muchmore JH, Prats I: Immunological heterogeneity in human melanoma: Immunogenic alloantigen expression in autologous host. Cancer Res 49:3706-3711, 1986

29. Muchmore JH, Krementz ET, Carter RD, Sutherland CM, Mendoza EA: Isolated perfusion of extremities for metastatic melanoma from an unknown primary lesion. So Med J 79:288-290, 1986

30. Sutherland CM, Muchmore JH, Carter RD: Response to aminoglutetimide following no response to Tamoxifen in breast cancer. So Med J 78:987-989, 1986

31. Krementz ET, Carter RD, Sutherland CM, Muchmore JH: Chemotherapy by regional perfusion for limb melanoma. Am Surg 53:94-96, 1987

32. Muchmore JH, Krementz ET, Kerstein MD: Non-invasive evaluation of the peripheral vasculature following regional hyperthermic chemotherapeutic perfusion. Am Surg 53:94-96, 1987

33. Varma DGK, Muchmore JH, Mizushima A: Computed tomography of infiltrating benign lipoma. CT 11:45-49, 1987

34. Krementz ET, Muchmore JH, Carter RD, Sutherland CM: Regional chemotherapy for melanoma of the limbs. Contr Oncol 29:247-260, 1988

35. Sutherland CM, Krementz ET, Carter RD, Muchmore JH: Randomized trials of heated perfusion of extremity melanoma. Cancer Treat Res 43:173-176, 1988

36 Carter RD, Faddis DM, Krementz ET, Puyau FA, Muchmore JH: Locally advanced breast cancer treated with regional intra-arterial chemotherapy. Reg Cancer Treat J 1:108-111, 1988

37. Englehardt TC, Godfrey RS, Levin AL, Muchmore JH: Surgical management of unresectable retroperitoneal leiomyosarcomas. J La State Med Soc 141:20-23, 1989

38.Muchmore JH, Krementz ET, Carter RD, Sutherland CM, Cieutat EG: Isolated regional perfusion for treatment of limb melanoma in the American Black. Am Surg 55(4):232-237, 1989

39. Muchmore JH, Dunlap JN, Culicchia F, Kerstein MD: Deep vein thrombophlebitis and pulmonary embolism in patients with malignant gliomas. So Med J 82(11):1352-1356, 1989

40.Muchmore JH, Krementz ET, Carter RD, Sutherland CM, Godfrey RS. Regional perfusion for the treatment of subungual melanoma. Am Surg 56:114-118,1990

41. Muchmore JH, Krementz ET, Carter RD, Meyer GM. Management of advanced intra-abdominal malignancy using high-dose intra-arterial chemotherapy with concomitant hemofiltration. Reg Cancer Treat 3:211-215, 1990

42. Meyer M, Muchmore JH, Krementz ET. Pre- and perioperative perfusion chemotherapy for soft tissue sarcoma of the limbs. Cancer Treat Res 1991; 56:105-126.

43. Muchmore JH, Krementz ET, Carter RD et al. Treatment of abdominal malignancies using regional chemotherapy with hemofiltration. Arch Surg 126:1390-1396, 1991

44. Muchmore JH, Scalia SV. Melanoma of the hand and foot (Acral Lentiginous Melanoma). The Melanoma Letter, 9:3-4, 1991

45. Sutherland CM, Mather FJ, Muchmore JH, Carter RD, Reed RJ, Krementz ET. Acral lentiginous melanoma: Results of protocol treatment by regional perfusion plus excisional surgery and analysis of prognosis factors. Am J Surg, 1993, 166:64-67

46. Beg MH, Muchmore JH, Carter RD, Krementz ET. Vaginal melanoma and the role of regional chemotherapy. J Surg Onc, 53:133-135, 1993

47. Muchmore JH, Krementz ET, Carter RD, Beg MH. Salvage treatment for patients with limb melanoma failing isolated regional perfusion. Melanoma Res, 3:31, 1993

48. Muchmore JH, Krementz ET, Carter RD, Beg MH. Malignant melanoma in the American Black. Melanoma Res, 3:49, 1993

49. Krementz ET, Muchmore JH, Sutherland CM. Intra-arterial infusion chemotherapy for melanoma. Melanoma Res, 3:94, 1993

50. Saha S, Meyer M, Krementz ET, Hoda S, Carter RD, Muchmore JH, Sutherland CM. Prognostic evaluation of intracranial metastases in malignant melanoma. Ann Surg Oncol, 1:38-44, 1994

51. Sutherland CM, Mather FJ, Muchmore JH, Carter RD, Krementz ET. Acral lentiginous melanoma. Am J Surg, 166:64-67, 1993. Permission to reprint requested by Yearbook of Dermatologic Surgery, Mosby-yearbook, 1994.

52. Krementz ET, Carter RD, Sutherland CM, Muchmore JH, Ryan R, Creech Jr O. Regional perfusion of melanoma - A 35 year experience. Ann Surg 1994;220:520-535.

53. Muchmore JH, Haddad CG, Goldwag S. Primary non-Hodgkin's lymphoma of the duodenum. Am Surg 1994;60:924-928.

54 Krementz ET, Muchmore JH, Carter RD, Sutherland CM. Multiple perfusions for melanoma. Melanoma Res 1994; 4 Suppl 1:39-44.

55. Muchmore JH. Treatment of Advanced Pancreatic Cancer with Regional Chemotherapy plus Hemofiltration. Semin Surg Oncol 1995; 11:154-167.

56. Muchmore JH, Beg MH, Carter RD, Preslan JE, George WJ. Treatment of advanced pancreatic cancer with regional chemotherapy plus hemofiltration. Reg Cancer Treat 1995;8:77-81.

57. Muchmore JH, Carter RD, Preslan JE, George WJ. Regional chemotherapy with hemofiltration, Rationale for a different approach to advanced pancreatic cancer. Hepatogastroenterol 1996;43:346-355.

58 Muchmore JH, Preslan JE, George WJ. Regional chemotherapy for inoperable pancreatic cancer. Cancer 1996;78:664-673.

59 Muchmore JH, Mizuguchi RS, Lee C. Malignant melanoma in the american black female. An unusual distribution of primary sites. J Am Coll Surg 1996;183:457-465.

60. Cantore M, Pederzoli P, Cornabla G, Fiorentini G, Guadagni S, Miserocchi L, Frassoldi A, Cervolo C, Smerieri F, and Muchmore JH. Intra-arterial chemotherapy for unresectable pancreatic cancer. Ann Oncol 2000; 11:569-573.

In Manuscript

1. Muchmore JH, Keller A, Madan AK. Malignant Melanoma in children and young adults:

Minimal deviation melanoma - A good prognostic indicator.

EDITORIALS

1. Muchmore JH. Regional chemotherapy plus hemofiltration for the treatment of regionally advanced malignancy. Cancer 1996; 78:941-943.

ABSTRACTS

1. Hornung MO, Krementz ET, Muchmore JH, Prats I: Melanoma DR antigen profiles and phenotypic variance in patients autoimmunized against epithelioid melanomas. AACR 23(1093):276, 1984

2. Hornung MO, Krementz ET, Muchmore JH, Sullivan KA: Clinical inhibition of melanoma associated with autoimmunization vs. a DR incompatible melanoma cell. AACR 26(1114):283, 1985

3. Muchmore JH, Krementz ET, Carter RD, Sutherland CM: Regional perfusion for the treatment of subungual melanoma. ICRCT ULM, 1987

4. Muchmore JH, Krementz ET, Carter RD, Sutherland CM, Godfrey RS: Regional perfusion for the treatment of subungual melanoma. SESC, 1988

5. Muchmore JH, Preslan J, Meyer M, Carter RD, Saha S, George W, Krementz ET. Pharmacokinetics of high-dose intra-arterial chemotherapy with concomitant hemofiltration. AACR 1989

6. Muchmore JH, Krementz ET, Carter RD, Saha S, Meyer M. Management of advanced intra-abdominal malignancy using a new technique of high-dose intra-arterial chemotherapy with concomitant hemofiltration. ICRCT Berchtesgaden 1989

7. Muchmore JH, Preslan J, Meyer M, Krementz ET, Carter RD, Saha S, George W. Pharmacokinetics of intra-arterial chemotherapy plus concomitant hemofiltration. ICRCT Berchtesgaden 1989

8. Muchmore JH, Krementz ET, Carter RD, et al.: Malignant melanoma in the American Black. Second International Conference on Melanoma, Venice, Italy, 1989

9. Muchmore JH, Meyer GM, Krementz ET, Carter RD, Preslan J, George W. Concomitant high-dose intra-arterial chemotherapy and hemofiltration in treating advanced regional abdominal malignancies. Southeastern Surgical Congress, Naples, Florida, 1990

10. Muchmore JH, Krementz ET, Carter RD, Preslan J, George W, Mesko T. Concomitant high-dose intra-arterial chemotherapy and hemofiltration in treating advanced regional abdominal malignancies. J Cancer Res Clin Oncol 116 (II)(Suppl): 1214,1990

11. Muchmore JH, Krementz ET, Carter RD, Preslan J, George W. Management of unresectable intra-abdominal malignancies using high-dose intra-arterial chemotherapy with concomitant hemofiltration: A new technique. Society of Surgical Oncology, 1991

12. Muchmore JH, Krementz ET, Carter RD, Preslan J, George W, Rees G. Treatment of advanced intra-abdominal or thoracic malignancies using high-dose intra-arterial chemotherapy with concomitant hemofiltration: A new technique. Third International Congress on Neo-Adjuvant Chemotherapy, Paris, France, 1991

13. Muchmore JH, Carter RD, Preslan J, George WJ. Treatment of advanced intraabdominal colorectal carcinoma using high-dose intraarterial chemotherapy with concomitant hemofiltration. Fifth International Conference on Advances in Regional Cancer Treatment, 4:32, 1991

14. Muchmore JH, Carter RD, Krementz ET, Preslan J, George WJ. Treatment of unresectable pancreatic cancer using high-dose intraarterial chemotherapy with concomitant hemofiltration. Fifth International Conference on Advances in Regional Cancer Treatment, 4:32, 1991

15. Muchmore JH, Krementz ET, Carter RD, Preslan J, George W. High-dose intraarterial chemotherapy with concomitant hemofiltration. Fifth International Conference on Advances in Regional Cancer Treatment, 4:32, 1991

16.Muchmore JH. Regional intraabdominal chemotherapy, current status and problems. Fifth International Conference on Advances in Regional Cancer Treatment, 4:33, 1991

17.Muchmore JH, Krementz ET, Carter RD, Preslan JE, George WJ. Treatment of advanced

Pancreatic cancer with regional chemotherapy plus hemofiltration. Society of Surgical

Oncology, 1991

18. Muchmore JH, Krementz ET, Carter RD, Beg MH. Salvage treatment for patients with limb melanoma failing isolated regional perfusion. Third International Congress on Melanoma, Venice, Italy: 3:31, 1993

19. Muchmore JH, Krementz ET, Carter RD, Beg MH. Malignant melanoma in the american black. Third International Conference on Melanoma, Venice, Italy: 3:49, 1993

20. Krementz ET, Muchmore JH, Sutherland CM. Intra-arterial infusion chemotherapy for melanoma. Third International Conference on Melanoma, Venice, Italy: 3:95, 1993

21. Saha S, Meyer M, Krementz ET, Carter RD, Muchmore JH, Sutherland CM. Prognostic evaluation of intracranial metastases in malignant melanoma. The 46th Annual Cancer Symposium, Los Angeles, 1993

22. Godfrey RS, Krementz ET, Muchmore JH, Agrawal K, Rider B, Daggett C. Selecting melanoma patients for thermochemotherapy. The 46th Annual Cancer Symposium, Los Angeles, 1993

23. Krementz ET, Muchmore JH, Sutherland CM. Intra-arterial infusion chemotherapy for melanoma. The 46th Annual Cancer Symposium, Los Angeles, 1993

24. Krementz ET, Muchmore JH, Carter RD, Sutherland CM, Ryan R. Regional perfusion of melanoma - A 35 year experience. Am Surg Assoc, 1994

25.Muchmore JH. Regional chemotherapy with chemofiltration. Cancer of the Pancreas: A Challenge for the Nineties, Providence, 1994

26.Krementz ET, Muchmore JH. Intrarterial infusion of chemotherapy for recurrent melanoma. International Conference on Advances in Regional Cancer Treatment,

1997.

27.Keller A, Muchmore JH. Minimal Deviation Melanoma in childhood melanoma: A good prognostic indicator. Louisiana Chapter of Am Coll Surg, January 1998.

28. Muchmore JH, Keller A, Madan AK. Melanoma in childhood and young adults: Minimal Deviation Melanoma – A good prognostic indicator. Fifth World Conference on Melanoma, 2001.

29.Muchmore JH, Madan A, Moitra V, Krementz ET. Isolated hyperthermic perfusion for limb melanoma in children and young adults. Fifth World

Contact this candidate